Gene Symbol | Gene ID | Gene Info |
---|---|---|
OLIG3
|
ENSG00000177468.5 | oligodendrocyte transcription factor 3 |
NEUROD2
|
ENSG00000171532.4 | neuronal differentiation 2 |
NEUROG2
|
ENSG00000178403.3 | neurogenin 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_37761414_37761565 | NEUROD2 | 2707 | 0.190922 | -0.88 | 1.7e-03 | Click! |
chr17_37762810_37762961 | NEUROD2 | 1311 | 0.342071 | -0.75 | 1.9e-02 | Click! |
chr17_37760675_37760938 | NEUROD2 | 3390 | 0.169629 | -0.59 | 9.6e-02 | Click! |
chr17_37763097_37763248 | NEUROD2 | 1024 | 0.429471 | -0.56 | 1.2e-01 | Click! |
chr17_37760008_37760159 | NEUROD2 | 4113 | 0.157156 | -0.54 | 1.4e-01 | Click! |
chr4_113439205_113439356 | NEUROG2 | 1952 | 0.306978 | 0.73 | 2.5e-02 | Click! |
chr4_113486318_113486469 | NEUROG2 | 49065 | 0.096125 | 0.71 | 3.3e-02 | Click! |
chr4_113438394_113438545 | NEUROG2 | 1141 | 0.442265 | -0.69 | 4.1e-02 | Click! |
chr4_113441883_113442034 | NEUROG2 | 4630 | 0.212201 | -0.52 | 1.5e-01 | Click! |
chr4_113436811_113437342 | NEUROG2 | 252 | 0.712915 | -0.48 | 1.9e-01 | Click! |
chr6_137738225_137738376 | OLIG3 | 77231 | 0.108803 | 0.57 | 1.1e-01 | Click! |
chr6_137818938_137819089 | OLIG3 | 3482 | 0.323476 | -0.49 | 1.8e-01 | Click! |
chr6_137736032_137736869 | OLIG3 | 79081 | 0.105666 | 0.18 | 6.5e-01 | Click! |
chr6_137818629_137818780 | OLIG3 | 3173 | 0.335733 | -0.10 | 7.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_27301899_27302732 | 2.81 |
EMILIN1 |
elastin microfibril interfacer 1 |
880 |
0.32 |
chr1_64980027_64980301 | 2.57 |
CACHD1 |
cache domain containing 1 |
43689 |
0.17 |
chr18_53167832_53168083 | 2.11 |
RP11-619L19.2 |
|
8551 |
0.19 |
chr9_4111551_4111753 | 2.10 |
GLIS3 |
GLIS family zinc finger 3 |
33541 |
0.19 |
chr1_32168571_32169014 | 1.99 |
COL16A1 |
collagen, type XVI, alpha 1 |
976 |
0.48 |
chr8_93151518_93151690 | 1.89 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
36090 |
0.24 |
chr9_77501796_77502826 | 1.82 |
TRPM6 |
transient receptor potential cation channel, subfamily M, member 6 |
48 |
0.97 |
chr3_120166222_120166413 | 1.74 |
FSTL1 |
follistatin-like 1 |
3521 |
0.32 |
chr9_20041214_20041376 | 1.74 |
ENSG00000266224 |
. |
211544 |
0.02 |
chr2_9768568_9768982 | 1.73 |
YWHAQ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
1970 |
0.33 |
chr13_80690133_80690433 | 1.68 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
223511 |
0.02 |
chr7_120631344_120631706 | 1.66 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
1849 |
0.35 |
chr6_148830702_148830920 | 1.65 |
ENSG00000223322 |
. |
14565 |
0.29 |
chr3_16219029_16219297 | 1.64 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
2947 |
0.33 |
chr11_3402636_3402787 | 1.62 |
ZNF195 |
zinc finger protein 195 |
2263 |
0.25 |
chr12_59312115_59312531 | 1.62 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
1004 |
0.56 |
chr5_87777080_87777231 | 1.61 |
TMEM161B-AS1 |
TMEM161B antisense RNA 1 |
54643 |
0.15 |
chr5_102002318_102002469 | 1.59 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
87292 |
0.1 |
chr10_123780829_123780980 | 1.59 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
547 |
0.82 |
chr3_114477857_114478359 | 1.58 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
10 |
0.99 |
chr12_114878290_114878441 | 1.57 |
TBX5-AS1 |
TBX5 antisense RNA 1 |
29271 |
0.18 |
chr2_46929840_46930123 | 1.55 |
SOCS5 |
suppressor of cytokine signaling 5 |
3655 |
0.26 |
chr1_85826637_85826852 | 1.52 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
43436 |
0.13 |
chr6_125698814_125699135 | 1.52 |
RP11-735G4.1 |
|
3504 |
0.35 |
chr10_4283577_4283877 | 1.51 |
ENSG00000207124 |
. |
273417 |
0.02 |
chr16_17444432_17444583 | 1.51 |
XYLT1 |
xylosyltransferase I |
120231 |
0.07 |
chr16_66638822_66640143 | 1.49 |
CMTM3 |
CKLF-like MARVEL transmembrane domain containing 3 |
58 |
0.95 |
chr4_178168243_178168508 | 1.49 |
RP11-487E13.1 |
Uncharacterized protein |
1552 |
0.47 |
chr13_96295623_96295774 | 1.47 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
181 |
0.96 |
chr15_56204998_56205389 | 1.47 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
2659 |
0.34 |
chr2_33822936_33823087 | 1.45 |
FAM98A |
family with sequence similarity 98, member A |
1333 |
0.53 |
chr1_229524899_229525061 | 1.44 |
ENSG00000252506 |
. |
6105 |
0.16 |
chr6_44509899_44510345 | 1.43 |
ENSG00000266619 |
. |
106744 |
0.06 |
chr16_74204020_74204218 | 1.43 |
PSMD7 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
126554 |
0.05 |
chr10_17119201_17119352 | 1.42 |
CUBN |
cubilin (intrinsic factor-cobalamin receptor) |
50560 |
0.15 |
chr4_86758761_86758912 | 1.41 |
ARHGAP24 |
Rho GTPase activating protein 24 |
9790 |
0.27 |
chr17_57624815_57624966 | 1.41 |
ENSG00000200889 |
. |
10030 |
0.19 |
chr5_15500949_15501183 | 1.41 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
481 |
0.89 |
chr13_99777458_99777679 | 1.40 |
DOCK9-AS2 |
DOCK9 antisense RNA 2 (head to head) |
37495 |
0.14 |
chr9_118359454_118359605 | 1.39 |
DEC1 |
deleted in esophageal cancer 1 |
455432 |
0.01 |
chr8_16890094_16890245 | 1.39 |
MICU3 |
mitochondrial calcium uptake family, member 3 |
5422 |
0.26 |
chr10_17256481_17257128 | 1.39 |
VIM-AS1 |
VIM antisense RNA 1 |
12093 |
0.15 |
chr4_20420225_20420376 | 1.39 |
SLIT2-IT1 |
SLIT2 intronic transcript 1 (non-protein coding) |
26488 |
0.25 |
chr12_50676560_50676711 | 1.38 |
LIMA1 |
LIM domain and actin binding 1 |
632 |
0.65 |
chr13_74314833_74314984 | 1.34 |
KLF12 |
Kruppel-like factor 12 |
254278 |
0.02 |
chr3_146767707_146767940 | 1.34 |
ENSG00000207156 |
. |
53323 |
0.17 |
chr10_109413658_109413819 | 1.33 |
ENSG00000200079 |
. |
192420 |
0.03 |
chr8_83170405_83170556 | 1.32 |
SNX16 |
sorting nexin 16 |
415379 |
0.01 |
chr9_117879769_117880175 | 1.32 |
TNC |
tenascin C |
506 |
0.85 |
chr6_148831295_148831530 | 1.32 |
ENSG00000223322 |
. |
13964 |
0.3 |
chr4_181950999_181951150 | 1.31 |
ENSG00000251742 |
. |
805187 |
0.0 |
chr13_24231073_24231332 | 1.31 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
77683 |
0.1 |
chrX_22652803_22652954 | 1.30 |
ENSG00000265819 |
. |
2231 |
0.45 |
chr10_6962147_6962542 | 1.30 |
PRKCQ |
protein kinase C, theta |
340081 |
0.01 |
chr1_150779976_150780304 | 1.29 |
CTSK |
cathepsin K |
230 |
0.9 |
chr2_152214178_152214367 | 1.28 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
166 |
0.95 |
chr7_94026049_94026200 | 1.27 |
COL1A2 |
collagen, type I, alpha 2 |
2251 |
0.42 |
chr16_14279913_14280368 | 1.27 |
MKL2 |
MKL/myocardin-like 2 |
434 |
0.86 |
chr15_85840280_85840431 | 1.27 |
ADAMTS7P4 |
ADAMTS7 pseudogene 4 |
26232 |
0.17 |
chr1_15653496_15653771 | 1.27 |
RP3-467K16.7 |
|
8327 |
0.16 |
chr12_105477204_105477480 | 1.27 |
ALDH1L2 |
aldehyde dehydrogenase 1 family, member L2 |
999 |
0.49 |
chr12_78334342_78334902 | 1.26 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr8_39770308_39770525 | 1.25 |
IDO1 |
indoleamine 2,3-dioxygenase 1 |
387 |
0.77 |
chr19_16403865_16404198 | 1.24 |
CTD-2562J15.6 |
|
355 |
0.85 |
chr1_22774320_22774792 | 1.24 |
ZBTB40 |
zinc finger and BTB domain containing 40 |
3788 |
0.29 |
chr20_19956550_19956867 | 1.24 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
41052 |
0.15 |
chr14_32964986_32965137 | 1.24 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
783 |
0.74 |
chr10_33620428_33620906 | 1.24 |
NRP1 |
neuropilin 1 |
2643 |
0.37 |
chr2_230994193_230994344 | 1.24 |
AC009950.2 |
|
4242 |
0.24 |
chr21_27960145_27960468 | 1.24 |
CYYR1 |
cysteine/tyrosine-rich 1 |
14703 |
0.29 |
chr18_72508950_72509103 | 1.24 |
ZNF407 |
zinc finger protein 407 |
166050 |
0.04 |
chr9_16828464_16828715 | 1.23 |
BNC2 |
basonuclin 2 |
3697 |
0.36 |
chr7_6267929_6268080 | 1.23 |
ENSG00000202273 |
. |
15633 |
0.17 |
chr7_16103631_16103828 | 1.23 |
ISPD-AS1 |
ISPD antisense RNA 1 |
146384 |
0.05 |
chr3_71151773_71151938 | 1.21 |
FOXP1 |
forkhead box P1 |
27889 |
0.26 |
chr7_137223183_137223374 | 1.20 |
PTN |
pleiotrophin |
194667 |
0.03 |
chr10_95137899_95138050 | 1.20 |
MYOF |
myoferlin |
103977 |
0.07 |
chr12_72671108_72671475 | 1.20 |
ENSG00000236333 |
. |
2604 |
0.33 |
chr7_41738474_41738677 | 1.20 |
INHBA |
inhibin, beta A |
1632 |
0.38 |
chr4_100021268_100021419 | 1.20 |
RP11-696N14.1 |
|
11241 |
0.17 |
chr3_115342492_115342792 | 1.20 |
GAP43 |
growth associated protein 43 |
285 |
0.94 |
chr15_40078221_40078372 | 1.19 |
FSIP1 |
fibrous sheath interacting protein 1 |
3265 |
0.21 |
chr12_64436496_64436647 | 1.19 |
RP11-196H14.2 |
|
54827 |
0.11 |
chr8_62686503_62686789 | 1.18 |
ENSG00000264408 |
. |
59299 |
0.14 |
chr8_93072084_93072309 | 1.18 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
2995 |
0.39 |
chr3_55178249_55178423 | 1.17 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
177221 |
0.03 |
chr8_105429971_105430182 | 1.17 |
ENSG00000222158 |
. |
7511 |
0.18 |
chr18_66468899_66469050 | 1.16 |
CCDC102B |
coiled-coil domain containing 102B |
3322 |
0.29 |
chr21_40984409_40984913 | 1.16 |
C21orf88 |
chromosome 21 open reading frame 88 |
87 |
0.97 |
chr10_92066299_92066534 | 1.15 |
ENSG00000222451 |
. |
142699 |
0.05 |
chr4_138463714_138463954 | 1.15 |
PCDH18 |
protocadherin 18 |
10186 |
0.33 |
chr22_46453201_46453794 | 1.14 |
RP6-109B7.3 |
|
2702 |
0.14 |
chr4_187149514_187149678 | 1.14 |
KLKB1 |
kallikrein B, plasma (Fletcher factor) 1 |
924 |
0.55 |
chr15_57512568_57512719 | 1.14 |
TCF12 |
transcription factor 12 |
979 |
0.67 |
chr6_56555918_56556226 | 1.13 |
DST |
dystonin |
48278 |
0.18 |
chr3_151694521_151694688 | 1.12 |
RP11-454C18.2 |
|
48641 |
0.17 |
chr5_91378447_91378598 | 1.12 |
ENSG00000264489 |
. |
363222 |
0.01 |
chr11_131618597_131618988 | 1.12 |
NTM |
neurotrimin |
87904 |
0.1 |
chr5_88129391_88129549 | 1.11 |
MEF2C |
myocyte enhancer factor 2C |
6495 |
0.28 |
chr18_32290285_32290488 | 1.11 |
DTNA |
dystrobrevin, alpha |
125 |
0.98 |
chr4_85713464_85713615 | 1.11 |
WDFY3-AS1 |
WDFY3 antisense RNA 1 |
10872 |
0.25 |
chr7_28771955_28772315 | 1.11 |
CREB5 |
cAMP responsive element binding protein 5 |
46537 |
0.2 |
chr8_37124215_37124389 | 1.11 |
RP11-150O12.6 |
|
250237 |
0.02 |
chr1_172367802_172367953 | 1.10 |
DNM3 |
dynamin 3 |
19719 |
0.15 |
chr6_56239740_56239891 | 1.10 |
COL21A1 |
collagen, type XXI, alpha 1 |
19077 |
0.21 |
chr4_119875149_119875300 | 1.09 |
SYNPO2 |
synaptopodin 2 |
65032 |
0.13 |
chr6_152700147_152700338 | 1.09 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
1439 |
0.39 |
chr1_110502486_110502637 | 1.09 |
AHCYL1 |
adenosylhomocysteinase-like 1 |
24747 |
0.14 |
chr4_160169630_160170007 | 1.08 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
18215 |
0.23 |
chr8_37310276_37310698 | 1.08 |
RP11-150O12.6 |
|
64052 |
0.13 |
chr18_32173182_32173613 | 1.08 |
DTNA |
dystrobrevin, alpha |
68 |
0.99 |
chr18_74198135_74198393 | 1.08 |
ZNF516 |
zinc finger protein 516 |
4471 |
0.19 |
chr5_91988534_91988685 | 1.07 |
ENSG00000221810 |
. |
64611 |
0.15 |
chr22_36367515_36367713 | 1.07 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
9900 |
0.29 |
chr2_227835215_227835366 | 1.07 |
ENSG00000212391 |
. |
1452 |
0.52 |
chr4_71892139_71892290 | 1.07 |
DCK |
deoxycytidine kinase |
32859 |
0.2 |
chr15_74221251_74221642 | 1.07 |
LOXL1-AS1 |
LOXL1 antisense RNA 1 |
857 |
0.51 |
chr5_88178054_88178448 | 1.06 |
MEF2C |
myocyte enhancer factor 2C |
713 |
0.52 |
chr2_41837870_41838465 | 1.06 |
ENSG00000221372 |
. |
14641 |
0.29 |
chr9_83052215_83052366 | 1.06 |
ENSG00000221581 |
. |
296954 |
0.01 |
chr6_129034296_129034447 | 1.05 |
ENSG00000202200 |
. |
48582 |
0.16 |
chrX_103554920_103555123 | 1.05 |
ESX1 |
ESX homeobox 1 |
55407 |
0.15 |
chr4_159991599_159991750 | 1.05 |
ENSG00000206978 |
. |
6124 |
0.19 |
chr11_128453017_128453335 | 1.05 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
4277 |
0.28 |
chr10_112853696_112853847 | 1.05 |
ADRA2A |
adrenoceptor alpha 2A |
16981 |
0.25 |
chr20_50044809_50044960 | 1.05 |
ENSG00000266761 |
. |
24630 |
0.22 |
chr20_8608297_8608449 | 1.05 |
ENSG00000222298 |
. |
17486 |
0.22 |
chr4_104013518_104013703 | 1.05 |
BDH2 |
3-hydroxybutyrate dehydrogenase, type 2 |
7376 |
0.22 |
chr3_11651889_11652286 | 1.04 |
VGLL4 |
vestigial like 4 (Drosophila) |
109 |
0.94 |
chr18_56244732_56244930 | 1.04 |
RP11-126O1.2 |
|
20529 |
0.14 |
chr2_221568543_221568694 | 1.04 |
ENSG00000222096 |
. |
226805 |
0.02 |
chr4_160189270_160189577 | 1.04 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
534 |
0.83 |
chr12_1583881_1584165 | 1.03 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
55034 |
0.12 |
chr12_26150238_26150389 | 1.03 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
2376 |
0.35 |
chr17_21163251_21163402 | 1.03 |
C17orf103 |
chromosome 17 open reading frame 103 |
6604 |
0.17 |
chrX_28607213_28607364 | 1.03 |
IL1RAPL1 |
interleukin 1 receptor accessory protein-like 1 |
1772 |
0.53 |
chr10_30248594_30248745 | 1.02 |
KIAA1462 |
KIAA1462 |
99784 |
0.08 |
chr6_13733598_13733910 | 1.02 |
RANBP9 |
RAN binding protein 9 |
21958 |
0.19 |
chr17_60868253_60868692 | 1.02 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
15529 |
0.23 |
chr4_38087118_38087269 | 1.01 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
39701 |
0.21 |
chr10_117577321_117577472 | 1.01 |
GFRA1 |
GDNF family receptor alpha 1 |
437911 |
0.01 |
chr19_16179581_16179939 | 1.01 |
TPM4 |
tropomyosin 4 |
1250 |
0.44 |
chr2_178261985_178262195 | 1.01 |
AGPS |
alkylglycerone phosphate synthase |
4594 |
0.16 |
chr5_15501266_15501663 | 1.01 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
83 |
0.99 |
chr15_89452927_89453078 | 1.01 |
MFGE8 |
milk fat globule-EGF factor 8 protein |
3591 |
0.23 |
chr20_21962515_21962666 | 1.01 |
PAX1 |
paired box 1 |
275729 |
0.02 |
chr14_69714308_69714466 | 1.00 |
GALNT16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
12294 |
0.22 |
chr12_111787634_111787785 | 1.00 |
ENSG00000253080 |
. |
10378 |
0.18 |
chr9_128521797_128522422 | 1.00 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
11631 |
0.27 |
chr16_66338384_66338535 | 1.00 |
ENSG00000201999 |
. |
2747 |
0.33 |
chr2_227050099_227050363 | 0.99 |
ENSG00000263363 |
. |
473278 |
0.01 |
chr9_132694844_132695111 | 0.99 |
RP11-409K20.6 |
|
838 |
0.62 |
chr17_878729_878960 | 0.99 |
NXN |
nucleoredoxin |
4166 |
0.16 |
chr12_104607992_104608143 | 0.98 |
TXNRD1 |
thioredoxin reductase 1 |
1490 |
0.44 |
chr7_83944851_83945002 | 0.98 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
120165 |
0.07 |
chr10_4805628_4805779 | 0.97 |
AKR1E2 |
aldo-keto reductase family 1, member E2 |
23118 |
0.25 |
chr7_33746403_33746586 | 0.96 |
RP11-89N17.1 |
HCG1643653; Uncharacterized protein |
19099 |
0.23 |
chr7_15725909_15726109 | 0.96 |
MEOX2 |
mesenchyme homeobox 2 |
428 |
0.88 |
chr6_85355280_85355431 | 0.96 |
RP11-132M7.3 |
|
43788 |
0.21 |
chr18_67067194_67067650 | 0.96 |
DOK6 |
docking protein 6 |
869 |
0.76 |
chr20_32119305_32119472 | 0.96 |
CBFA2T2 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
30752 |
0.15 |
chr16_64245174_64245639 | 0.96 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
848175 |
0.0 |
chr2_206272712_206272863 | 0.96 |
NRP2 |
neuropilin 2 |
274437 |
0.02 |
chr11_73023790_73024080 | 0.95 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
1325 |
0.34 |
chr3_194973546_194973732 | 0.95 |
XXYLT1 |
xyloside xylosyltransferase 1 |
4990 |
0.19 |
chr4_72116788_72116939 | 0.95 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
63819 |
0.15 |
chr7_92241576_92241727 | 0.95 |
FAM133B |
family with sequence similarity 133, member B |
21943 |
0.2 |
chr13_20535826_20536004 | 0.95 |
ZMYM2 |
zinc finger, MYM-type 2 |
2992 |
0.28 |
chr3_55195022_55195238 | 0.94 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
194015 |
0.03 |
chr12_124072320_124072609 | 0.93 |
TMED2 |
transmembrane emp24 domain trafficking protein 2 |
2355 |
0.2 |
chr7_73443076_73443679 | 0.93 |
ELN |
elastin |
859 |
0.62 |
chr10_4814227_4814378 | 0.93 |
AKR1E2 |
aldo-keto reductase family 1, member E2 |
14519 |
0.27 |
chr13_26955922_26956073 | 0.93 |
CDK8 |
cyclin-dependent kinase 8 |
127218 |
0.05 |
chr22_45865037_45865472 | 0.93 |
RP1-102D24.5 |
|
20630 |
0.17 |
chr9_17005379_17005546 | 0.93 |
ENSG00000241152 |
. |
48437 |
0.18 |
chr2_164592268_164592669 | 0.93 |
FIGN |
fidgetin |
49 |
0.99 |
chr3_66536149_66536300 | 0.92 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
15132 |
0.29 |
chr8_58899386_58899537 | 0.92 |
FAM110B |
family with sequence similarity 110, member B |
7652 |
0.34 |
chr8_41365915_41366092 | 0.91 |
GOLGA7 |
golgin A7 |
17830 |
0.14 |
chr18_53068422_53068903 | 0.91 |
TCF4 |
transcription factor 4 |
96 |
0.98 |
chr2_20898985_20899233 | 0.91 |
GDF7 |
growth differentiation factor 7 |
32685 |
0.19 |
chr18_8615592_8616115 | 0.91 |
RAB12 |
RAB12, member RAS oncogene family |
6410 |
0.21 |
chr12_105477554_105478290 | 0.91 |
ALDH1L2 |
aldehyde dehydrogenase 1 family, member L2 |
419 |
0.81 |
chr17_46177753_46179071 | 0.91 |
CBX1 |
chromobox homolog 1 |
148 |
0.91 |
chr9_80091380_80091540 | 0.91 |
RP11-466A17.1 |
|
20249 |
0.25 |
chr4_159093168_159093728 | 0.91 |
RP11-597D13.9 |
|
281 |
0.64 |
chr12_21981834_21982050 | 0.90 |
RP11-729I10.2 |
|
1798 |
0.39 |
chr18_56533300_56533451 | 0.90 |
ZNF532 |
zinc finger protein 532 |
589 |
0.75 |
chr3_148366543_148366694 | 0.90 |
AGTR1 |
angiotensin II receptor, type 1 |
48953 |
0.18 |
chr8_72770231_72770526 | 0.90 |
MSC |
musculin |
13675 |
0.18 |
chr3_87036535_87037613 | 0.89 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr8_124038127_124038278 | 0.89 |
DERL1 |
derlin 1 |
190 |
0.93 |
chrX_135287285_135287436 | 0.89 |
FHL1 |
four and a half LIM domains 1 |
480 |
0.84 |
chr1_170380205_170380356 | 0.89 |
ENSG00000263384 |
. |
40844 |
0.18 |
chr10_93073745_93074042 | 0.89 |
PCGF5 |
polycomb group ring finger 5 |
93348 |
0.09 |
chr20_22777018_22777212 | 0.89 |
ENSG00000265151 |
. |
63176 |
0.14 |
chr9_12775045_12775253 | 0.89 |
LURAP1L |
leucine rich adaptor protein 1-like |
129 |
0.97 |
chr2_216296824_216297216 | 0.89 |
FN1 |
fibronectin 1 |
3770 |
0.26 |
chr5_102014115_102014266 | 0.89 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
75495 |
0.12 |
chr15_57427212_57427363 | 0.89 |
TCF12 |
transcription factor 12 |
84341 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 2.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 1.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.4 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 1.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 2.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 0.6 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.3 | 1.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.3 | 0.8 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.3 | 1.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 1.3 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.8 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.7 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 2.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 1.0 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 1.0 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.2 | 0.8 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 1.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.2 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.9 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0060753 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 1.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.1 | 0.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.1 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0060536 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.1 | 1.0 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.4 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 1.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 1.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.3 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.3 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 1.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.2 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.2 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.1 | 0.7 | GO:0006568 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.3 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.3 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.3 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.6 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.1 | 0.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.3 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.3 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.5 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.2 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0061082 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) myeloid leukocyte cytokine production(GO:0061082) |
0.0 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.0 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.9 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.3 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.3 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 1.6 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.3 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) positive regulation of dendrite development(GO:1900006) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.0 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.2 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.0 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.3 | GO:0030818 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.2 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.3 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.0 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.4 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 1.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.0 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.5 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.0 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.0 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 1.3 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.0 | 1.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.2 | GO:0070371 | ERK1 and ERK2 cascade(GO:0070371) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0021587 | cerebellum morphogenesis(GO:0021587) |
0.0 | 0.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 2.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 13.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 2.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 2.0 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 1.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 6.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.6 | 1.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 1.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 1.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.4 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 0.3 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 2.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.2 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.3 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 1.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 6.0 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 1.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 4.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 13.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 4.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.9 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |